$72.00
PT-141, also known as Bremelanotide, is a synthetic peptide developed as a melanocortin receptor agonist for the treatment of sexual dysfunction in both men and women. Unlike drugs that act on vascular pathways, PT-141 targets the central nervous system to enhance sexual desire and arousal, making it a novel option for individuals with low libido who may not respond to traditional hormone or PDE5-based therapies.
55 in stock
PT-141 (10mg) is a synthetic PT-141 peptide, which is also known as Bremelanotide, that is made to interact with melanocortin receptors that are involved in sexual function and neurological signalling.
It is a freeze-dried powder form that is mixed with water before usage in research settings.
Research is going on on how PT-141 (10mg) helps in improving sexual desire and arousal by working on the central nervous system instead of the vascular pathway.
Studies are focusing on how the PT-141 peptide affects brain signals to develop sexual motivation, which makes it an important compound in lowering libido in both males and females.
Like other traditional medicines and treatments, PT-141 works on the hormone or PDE5 pathway independently.
It works by binding to melanocortin receptors in the brain, which helps regulate sexual desire and arousal.
Rather than targeting the blood flow, this peptide acts on the neurological pathway by increasing sexual signals and behaviour.
Findings: Improved sexual desire and satisfaction vs placebo in women with HSDD
Findings: Increased sexual function; well-tolerated with nausea as the most common side effect
Findings: Low incidence of serious side effects, effective in improving sexual desire
Findings: Significant improvement in sexual satisfaction and libido compared to placebo
Findings: Demonstrated benefits in male libido and erectile response, even in non-responders to traditional ED meds
Findings: Pre-sexual activity use led to greater arousal and satisfaction in women with HSDD
Findings: Central nervous system effects show promise as an alternative ED therapy
Note : Please review and adhere to our Terms and Conditions before ordering
Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Molecular Weight: ≈ 1025.2 g/mol (Da)
Epithalon is a synthetic tetrapeptide studied for its potential role in cellular ageing, telomere regulation, and biological longevity. It has been studied for its potential role in telomerase activity, telomere length regulation, sleep-related pathways, immune response, and oxidative stress. With a strong history of research in Russia and Europe, Epithalon is investigated for its potential in delaying biological ageing and improving overall life span.
| Quantity | 25mg |
|---|
GLP-1 T It is the first dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist being studied for enhancing glycemic control and inducing significant weight loss. Its dual action makes it more effective than traditional GLP-1 therapies in both metabolic and cardiovascular health domains.
| Quantity | 10mg, 20mg |
|---|
GLP-1 R activates GLP-1, GIP, and glucagon receptors and is used in laboratory research to study metabolic pathways, receptor activity, and peptide interactions. Compounds like this are commonly studied in preclinical and research settings to explore potential therapeutic mechanisms.
| Quantity | 16mg, 24mg |
|---|
DSIP 5mg is a compound for managing insomnia, reducing anxiety, supporting physical recovery, and providing neuroprotection. It acts on delta brain wave activity and influences the endocrine system, making it a valuable compound in research for managing insomnia, reducing anxiety, supporting physical recovery, and providing neuroprotection. DSIP is under research, especially for its usefulness in sleep disturbances, chronic stress, or neurodegenerative studies.
| Quantity | 5mg |
|---|
